How does first-line infliximab compare with standard induction treatment for children with newly diagnosed moderate to severe Crohn's disease?

Cochrane Clinical Answers 2026

View at publisher
Authors: Kurinchi Selvan Gurusamy
DOI: 10.1002/cca.4675
Cited by: 0
References: 1

Fields of Study & Subjects

Inflammatory Bowel Disease Ocular Diseases and Behçet’s Syndrome Autoimmune and Inflammatory Disorders Research

Publication details

Journal / source
Cochrane Clinical Answers
Publication date
6 February 2026
Language
EN